LexisNexis® Legal News Podcast for November 2, 2009
Stryker Biotech and four executives are indicted for off-label sales of bone repair products, and, ExxonMobil says it will settle MTBE claims for $17.5 million. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
No related posts.




facebook
rss
twitter